Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

8.7 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 124.968422.765239.616270.391230.784241.179189.21149.26885.262120.864388.877262.731284.309297.16309.996154.8743.7280
Short Term Investments 406.752135.618122.2547.553135.563164.359253.671268.911257.007253.4775.9870000000
Cash and Short Term Investments 531.72558.383361.866317.944366.347405.538442.882318.179342.269374.341394.864262.731284.309297.16309.996154.8743.72827.332
Net Receivables 13.8768.6959.136000000000000000
Inventory 3.3212.7350.151000000000000000
Other Current Assets 13.41311.18312.0058.098.9277.7536.9024.2095.6056.1727.6394.6375.0596.1516.0290.1151.3430
Total Current Assets 562.33580.996383.158326.034375.274405.538449.784322.388347.874380.513402.503267.368289.368303.311316.025158.75545.07127.332
Non-Current Assets:
Property, Plant & Equipment, Net 4.7073.4780.360.4440.560.6550.7130.6880.7190.8991.060.2460.2840.3350.3860.4350.4830
Goodwill 000000000000000000
Intangible Assets 15.6316.21616.802000000000000000
Goodwill and Intangible Assets 15.6316.21616.802000000000000000
Long Term Investments 000000000000000000
Tax Assets 000000000000000000
Other Non-Current Assets 0.1210.1170.1170.1670.2147.9860.2590.4870.4690.4490.4840.1650.1690.1370.1261.690.107-27.332
Total Non-Current Assets 20.45819.81117.2790.6110.7748.6410.9721.1751.1881.3481.5440.4110.4530.4720.5122.1250.59-27.332
Total Assets 582.788600.807400.437326.645376.048414.179450.756323.563349.062381.861404.047267.779289.821303.783316.537160.8845.6610
Liabilities & Equity:
Current Liabilities:
Account Payables 3.2623.0176.4444.782.5763.3914.5654.6570.263.9730.4390.7011.7440.6830.3480.6860.2020
Short Term Debt 0.020.1540.380.30.8160.8740.8560.8340.4050.9240.8540.3420.2040.4040.4020.1990.1980
Tax Payables 000000000000000000
Deferred Revenue 1.5541.4620025.48320.23819.33300011.77206.6054.9764.0192.1741.5690
Other Current Liabilities 68.61535.11286.88224.75926.11620.2119.09117.35715.9513.37411.5067.1336.7094.9593.9122.1811.5960
Total Current Liabilities 73.45139.74593.70629.83929.50824.47524.51222.84816.61518.27112.7998.1768.6576.0464.6623.0661.9960
Non-Current Liabilities:
Long Term Debt 2.5922.5380000.0770.190.30.4080.5140.61700.0160.0650.1120.1590.2040
Deferred Revenue Non-Current 3.2333.0610000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 0.76100000000000000221.72191.964-25.318
Total Non-Current Liabilities 6.5865.5990000.0770.190.30.4080.5140.6170.8720.0160.0650.112221.8892.168-25.318
Total Liabilities 80.03745.34493.70629.83929.508818.25324.70223.14817.02318.78513.4168.1768.6736.1114.774224.94694.164-25.318
Equity:
Preferred Stock 0000000000000303.78304.783030.504
Common Stock 0.010.010.0090.0090.0090.0090.0090.0070.0070.0070.0070.0060.0060.0060.006220
Retained Earnings -554.081-488.367-525.404-520.997-458.585-404.074-357.924-312.061-269.668-229.559-191.764-155.234-127.487-105.548-86.308-72.024-56.8420
Accumulated Other Comprehensive Income/Loss 0.084-0.006-0.022-0.0050.009-0.007-0.0090.067-0.071-0.392-0.00300-303.783000-10.673
Other Total Stockholders Equity 1,056.7381,043.826832.148817.799805.107793.699783.978612.402601.771593.02582.391414.831408.629706.997398.065-3.60892.6015.487
Total Shareholders Equity 502.751555.463306.731296.806346.54-404.074426.054-312.061332.039363.076390.631259.603-127.487297.672311.763-68.849-54.20525.318
Total Equity 502.751555.463306.731296.806346.54-404.074426.054-312.061332.039363.076390.631259.6030000025.318
Total Liabilities & Shareholders Equity 582.788600.807400.437326.645376.048414.179450.756-288.913349.062381.861404.047267.779-118.814303.783316.537160.8845.6610